These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 386390)

  • 21. [A comparative study of viloxazine and imipramine (author's transl)].
    Floru L; Tegeler J
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jul; 12(4):313-20. PubMed ID: 386389
    [No Abstract]   [Full Text] [Related]  

  • 22. Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study.
    Petrie WM; Ban TA; Wilson WH; Jamieson RC; Guy W
    Int Pharmacopsychiatry; 1982; 17(4):280-6. PubMed ID: 7185772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Double blind comparison of the antidepressives viloxazine and imipramine (author's transl)].
    Pöldinger W
    Dtsch Med Wochenschr; 1982 Apr; 107(17):661-5. PubMed ID: 7075479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative speed of onset of the antidepressant effect of maprotiline.
    Silverstone T
    Clin Ther; 1981; 3(5):374-81. PubMed ID: 7471133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
    Rao ML; Deister A; Laux G; Staberock U; Höflich G; Möller HJ
    Pharmacopsychiatry; 1996 May; 29(3):97-102. PubMed ID: 8738313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viloxazine in the treatment of depression: psychophysical measures and clinical response.
    Amin MM; Ban TA; Lehmann HE; Khan P
    Psychopharmacol Bull; 1978 Jan; 14(1):33-5. PubMed ID: 625536
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
    Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The antidepressant viloxazin. A multicenter study under practice conditions].
    Rüther E
    Fortschr Med; 1982 May; 100(18):864-70. PubMed ID: 6124490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of amitriptyline and therapeutic effect in non-delusional moderately to severely depressed in-patients: a therapeutic window relationship.
    Ulrich S; Northoff G; Wurthmann C; Partscht G; Pester U; Herscu H; Meyer FP
    Pharmacopsychiatry; 2001 Jan; 34(1):33-40. PubMed ID: 11229620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of adinazolam, amitriptyline, and diazepam in endogenous depressive inpatients exhibiting DST nonsuppression or abnormal contingent negative variation.
    Ansseau M; Devoitille JM; Papart P; Vanbrabant E; Mantanus H; Timsit-Berthier M
    J Clin Psychopharmacol; 1991 Jun; 11(3):160-5. PubMed ID: 2066454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraindividual comparison of the antidepressant effectivity of viloxazine and maprotiline.
    Dostal T; Kabes J
    Act Nerv Super (Praha); 1978 Dec; 20(4):252-3. PubMed ID: 735720
    [No Abstract]   [Full Text] [Related]  

  • 33. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial.
    Altamura AC; De Novellis F; Guercetti G; Invernizzi G; Percudani M; Montgomery SA
    Int J Clin Pharmacol Res; 1989; 9(6):391-6. PubMed ID: 2699465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
    Baldwin D; Bridgman K; Buis C
    J Psychopharmacol; 2006 Jan; 20(1):91-6. PubMed ID: 16204325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Viloxazine in the treatment of depression in the aged. Double-blind placebo study].
    De Leo D; Ceola A; Magni G; Renesto V; Pacchioni A
    Minerva Psichiatr; 1984; 25(2):127-30. PubMed ID: 6387360
    [No Abstract]   [Full Text] [Related]  

  • 38. [Viloxazine. Aspects of the therapeutic effect of the antidepressive agent viloxazine (Vivalan ICI) in the opinion of practicing neurologists].
    Jungkunz G
    MMW Munch Med Wochenschr; 1982 Aug; 124(32-33):712-4. PubMed ID: 6813688
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lofepramine: a comparative clinical study with amitriptyline].
    Mariategui J; Chávez H; Olivares A
    Acta Physiol Lat Am; 1978 Sep; 24(3):201-9. PubMed ID: 375679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative double-blind controlled study of trimipramine and amitriptyline in major depression: lack of correlation with 5-hydroxytryptamine reuptake blockade.
    Cournoyer G; de Montigny C; Ouellette J; Langlois R; Elie R; Caille G; le Morvan P
    J Clin Psychopharmacol; 1987 Dec; 7(6):385-93. PubMed ID: 3323262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.